Injection Site Reactions : Local irritation, pain, or swelling at the injection site may occur in some patients
As GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro become increasingly common in both diabetes and weight loss management, a new clinical challenge is emerging: patients are reporting gastrointestinal symptoms that are difficult to differentiate from underlying disorders
Same drug, same injection, different label on the box, different answer from the insurer
final recommendations are made after a medical evaluation
We recommend these resources based on your weight loss goals Request an Appointment Call 800.239.7830 to schedule now or fill out form and we will contact you within 48 hours
Abstract Background Knee osteoarthritis (KOA) is a disability-associated condition that is rapidly growing with the increase in obesity rates worldwide